Sulfasalazine Dosing for Psoriatic Arthritis

Initial Dosing Strategy

• The American Academy of Dermatology recommends starting sulfasalazine at 500 mg orally twice daily and escalating to a target dose of 2 grams daily (1 gram twice daily) to minimize gastrointestinal intolerance, which occurs in up to one-third of patients 1, 2
• The target therapeutic dose for PsA is 2 grams daily (1 gram twice daily), as this dose has demonstrated efficacy in the largest controlled trial 2

Evidence for 2 Gram Daily Dose

• The largest Department of Veterans Affairs trial (221 patients) used 2 grams daily and showed 58% of sulfasalazine-treated patients achieved response criteria compared to 45% on placebo after 36 weeks 1, 2

Expected Timeline for Response

• Full assessment of efficacy should occur at 12 weeks, consistent with treat-to-target principles 3
• If inadequate response after 12 weeks at target dose, switch to a biologic DMARD rather than continuing sulfasalazine 3

Important Caveats

• Sulfasalazine is not effective for axial disease in PsA (spinal involvement), only for peripheral arthritis 4
• The 2024 EULAR guidelines position sulfasalazine as a conventional synthetic DMARD option alongside methotrexate and leflunomide, but note that methotrexate is generally preferred 3
• Folate supplementation is required as sulfasalazine interferes with folate metabolism 5, 6

Monitoring Requirements

• CBC and liver function tests should be performed every 2 weeks for the first 3 months, then monthly for the second 3 months, then every 3 months thereafter 1, 2, 7
• Periodic urinalysis and renal function tests should be performed 1, 2, 7
• Pregnancy testing is recommended if indicated (Category B in pregnancy) 1, 2, 7